Search research articles
Contact Us
Filters
Showing results (271-280 of 294) with videos related to
Page
of 30
Sort By:
Blood Cancer Journal
|
November 2, 2025
Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma
Eric Jurgens, Tala Shekarkhand, Colin Rueda, et al.
Blood Cancer Journal
|
April 12, 2026
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma
Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve, et al.
Blood Cancer Journal
|
May 31, 2024
Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
Karthik Nath, Tala Shekarkhand, David Nemirovsky, et al.
Medicina
|
May 23, 2020
[Consenso Argentino Intersociedades de Infección Urinaria 2018-2019 - Parte I]
Corina Nemirovsky, María José López Furst, Daniel Pryluka, et al.
Plos One
|
October 8, 2021
Clinical characteristics and outcomes of hospitalized patients with SARS-CoV-2 infection in a Latin American country: Results from the ECCOVID multicenter prospective study
Ezequiel Cordova, Analia Mykietiuk, Omar Sued, et al.
Hemasphere
|
December 1, 2025
Patterns and safety of glucocorticosteroid use following CD19 CAR-T therapy for large B-cell lymphoma
Efrat Luttwak, David Nemirovsky, Sean M Devlin, et al.
Blood Advances
|
March 6, 2025
Restarting Teclistamab and Talquetamab after Prolonged Dose Delay May Not Require Re-Step-up Dosing
Carlyn R Tan, Alice X Wang, David Nemirovsky, et al.
Blood Advances
|
May 2, 2025
Outcomes in Frail Patients Receiving BCMA-directed Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma
Benjamin O Adegbite, Carlyn Rose Tan, Tala Shekarkhand, et al.
JAMA Oncology
|
May 15, 2025
Barriers to Chimeric Antigen Receptor T-Cell Therapy
Yannis K Valtis, Kuo-Kai Chin, David Nemirovsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2025
Immune-MRD status informs tumor-MRD outcome prognostication in patients with multiple myeloma on lenalidomide maintenance
Ross S Firestone, Anish K Simhal, Devin McAvoy, et al.
Page
of 30
Search research articles
Search
Showing results (271-280 of 294) with videos related to
Sort By:
Page
of 30
Blood Cancer Journal
|
November 2, 2025
Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma
Eric Jurgens, Tala Shekarkhand, Colin Rueda, et al.
Blood Cancer Journal
|
April 12, 2026
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma
Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve, et al.
Blood Cancer Journal
|
May 31, 2024
Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
Karthik Nath, Tala Shekarkhand, David Nemirovsky, et al.
Medicina
|
May 23, 2020
[Consenso Argentino Intersociedades de Infección Urinaria 2018-2019 - Parte I]
Corina Nemirovsky, María José López Furst, Daniel Pryluka, et al.
Plos One
|
October 8, 2021
Clinical characteristics and outcomes of hospitalized patients with SARS-CoV-2 infection in a Latin American country: Results from the ECCOVID multicenter prospective study
Ezequiel Cordova, Analia Mykietiuk, Omar Sued, et al.
Hemasphere
|
December 1, 2025
Patterns and safety of glucocorticosteroid use following CD19 CAR-T therapy for large B-cell lymphoma
Efrat Luttwak, David Nemirovsky, Sean M Devlin, et al.
Blood Advances
|
March 6, 2025
Restarting Teclistamab and Talquetamab after Prolonged Dose Delay May Not Require Re-Step-up Dosing
Carlyn R Tan, Alice X Wang, David Nemirovsky, et al.
Blood Advances
|
May 2, 2025
Outcomes in Frail Patients Receiving BCMA-directed Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma
Benjamin O Adegbite, Carlyn Rose Tan, Tala Shekarkhand, et al.
JAMA Oncology
|
May 15, 2025
Barriers to Chimeric Antigen Receptor T-Cell Therapy
Yannis K Valtis, Kuo-Kai Chin, David Nemirovsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2025
Immune-MRD status informs tumor-MRD outcome prognostication in patients with multiple myeloma on lenalidomide maintenance
Ross S Firestone, Anish K Simhal, Devin McAvoy, et al.
Page
of 30